About
Technology
Issues
FAQ
Links
Official Page
Effects of immunomodulatory treatment with subcutaneous interferon beta-1a oncognitive decline in mildly disabled patients with relapsing—remitting multiple sclerosis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.